Abstract:The enzyme FabH plays a critical role in the initial step of fatty acid biosynthesis, which is vital for the survival of bacteria. As a result, FabH has emerged as an appealing target for the development of novel antibacterial agents. In this study, employing the chemical proteomics method, we validated the previously identified skeleton amide derivatives bearing dioxygenated rings, potentially formed through metabolic processes. Building upon the proteomics findings, we then synthesized and evaluated 32 compounds containing N -heterocyclic amides for their antimicrobial activity for future optimizing the deoxygenated amides. Several compounds demonstrated potent antimicrobial properties with low toxicity, particularly compound 25 , which exhibited remarkable potential as an agent with an MIC range of 1.25–3.13 μg/mL against the tested bacterial strains and an IC 50 of 2.0 μM against E. coli -derived FabH. Furthermore, we evaluated nine analogues with relatively low MIC values through cytotoxicity and hemolytic activity assessments, Lipinski's rule-of-five criteria, and in silico ADMET predictions to ascertain their druggability potential. Notably, a detailed docking simulation was performed to investigate the binding interactions of compound 25 within the binding pocket of E. coli FabH, which encouragingly revealed strong binding interactions. Based on our findings, compound 25 emerges as the optimal candidate for in vivo therapy aimed at treating infected skin defects. Remarkably, the application of compound 25 demonstrated a significant reduction in the duration of wound infection and notably accelerated the healing process of infected wounds, achieving an impressive 94 % healing rate by day 10.

Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis.

Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.

Design, Synthesis and Biological Evaluation of Amino Organophosphorus Imidazoles As a New Type of Potential Antimicrobial Agents

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Design, Synthesis and Antimicrobial Activities of Nitroimidazole Derivatives Containing 1,3,4-Oxadiazole Scaffold As Fabh Inhibitors

Design and Synthesis of Thiazole Derivatives As Potent FabH Inhibitors with Antibacterial Activity.

Synthesis, molecular modeling and biological evaluation of β-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents

Discovery of Novel Bacterial FabH Inhibitors (Pyrazol-Benzimidazole Amide Derivatives): Design, Synthesis, Bioassay, Molecular Docking and Crystal Structure Determination

Synthesis and antibacterial evaluation of novel Schiff's base derivatives of nitroimidazole nuclei as potent E. coli FabH inhibitors

Design, Synthesis and Antibacterial Activities of 5-(Pyrazin-2-yl)-4h-1,2,4-triazole-3-thiol Derivatives Containing Schiff Base Formation As FabH Inhibitory.

Design, Synthesis and Biological Evaluation of Novel Thiazole Derivatives As Potent FabH Inhibitors

Design, Synthesis and Antimicrobial Activities Evaluation of Schiff Base Derived from Secnidazole Derivatives As Potential FabH Inhibitors.

Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.

Synthesis, Molecular Docking and Biological Evaluation of Metronidazole Derivatives Containing Piperazine Skeleton As Potential Antibacterial Agents

Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity

Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.

Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors

Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors

Design and Synthesis of Potent Inhibitors of Beta-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As Potential Antibacterial Agents.

Design, Synthesis, and Antibacterial Evaluation of New Schiff’s Base Derivatives Bearing Nitroimidazole and Pyrazole Nuclei As Potent E. Coli FabH Inhibitors